Literature DB >> 16698380

Xanthine urolithiasis.

Vernon M Pais1, Gregory Lowe, Costas D Lallas, Glenn M Preminger, Dean G Assimos.   

Abstract

Xanthine calculi are uncommonly encountered stones. When they occur, they typically do so in association with inborn metabolic disorders such as hereditary xanthinuria or Lesch-Nyhan syndrome. They may also occur in association with states of profound hyperuricemia such as myeloproliferative disease after treatment with allopurinol. If the underlying disorder is not addressed, a high risk of stone recurrence exists. Therefore, to raise clinical awareness, we reviewed and report our experience in the treatment of patients with these stones, discussing the underlying pathophysiology and approach to treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698380     DOI: 10.1016/j.urology.2005.10.057

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

Review 1.  A focused review of the pathogenesis, diagnosis, and management of tumor lysis syndrome for the interventional radiologist.

Authors:  Marcia Friedman; Pritesh R Patel; Damiano Rondelli
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Recurrent kidney stones in a child with Lesch-Nyhan syndrome: Answers.

Authors:  Natasha Ng; Amrit Kaur; Mohan Shenoy
Journal:  Pediatr Nephrol       Date:  2018-08-15       Impact factor: 3.714

Review 3.  Diagnosis and management of non-calcium-containing stones in the pediatric population.

Authors:  Saritha Ranabothu; Ari P Bernstein; Beth A Drzewiecki
Journal:  Int Urol Nephrol       Date:  2018-05-30       Impact factor: 2.370

Review 4.  The tumor lysis syndrome.

Authors:  Scott C Howard; Deborah P Jones; Ching-Hon Pui
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 5.  [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium].

Authors:  T Knoll; T Bach; U Humke; A Neisius; R Stein; M Schönthaler; G Wendt-Nordahl
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

Review 6.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

7.  Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.

Authors:  Michael R Wiederkehr; Orson W Moe
Journal:  Clin Rev Bone Miner Metab       Date:  2011-12

Review 8.  Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants.

Authors:  Rosa J Torres; Juan G Puig; H A Jinnah
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 9.  Drug-Induced Urolithiasis in Pediatric Patients.

Authors:  Maria Chiara Sighinolfi; Ahmed Eissa; Luigi Bevilacqua; Ahmed Zoeir; Silvia Ciarlariello; Elena Morini; Stefano Puliatti; Viviana Durante; Pier Luca Ceccarelli; Salvatore Micali; Giampaolo Bianchi; Bernardo Rocco
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

10.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.